Management of Challenging Behaviors in Autism Spectrum Disorder Series

Tuesday, February 18, 2025, 6:00 PM - Wednesday, May 14, 2025, 1:00 PM, Teleconference


AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Attendance (4.00 hours)

This CME activity was designed to increase the knowledge and competence of primary care providers in the care of patients with Autism Spectrum Disorder (ASD) and challenging or interfering behaviors. It is a 4-part synchronous didactic series with opportunities for additional case consultation and asynchronous learning activities. 

Upcoming Sessions:

Topic	Date, Time, Speaker	Date, Time, Speaker
Management of Challenging Behaviors in Autism Spectrum Disorder	February 18, 6-7PM, presented by Elyse Schoenwald, NP	February 19, 12-1PM, presented by Peter Chung, MD
Autism Spectrum Disorder and Management: ADHD	March 10, 6-7PM, presented by Elyse Schoenwald, NP	March 19, 12-1PM, presented by Peter Chung, MD
Autism Spectrum Disorder and Management: Anxiety	April 14, 6-7PM, presented by Elyse Schoenwald, NP	April 30, 12-1PM, presented by Peter Chung, MD
Autism Spectrum Disorder and Management: Irritability	May 12, 6-7PM, presented by Elyse Schoenwald, NP	May 14, 12-1PM, presented by Peter Chung, MD

 

Tuesdays events are from 6 to 7 p.m. and Wednesday events from Noon to 1 p.m. Both sessions will cover the same content. You get to choose which session to attend.

1. Describe the approach to a patient with autism spectrum disorder (ASD) presenting with difficult or challenging behaviors
2. List methods useful in screening for behavioral conditions in ASD
3. Explain the challenges of using behavioral medications for patients with ASD
4. Describe the clinical approach to a patient with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD)
5. Apply strategies regarding the titration and dosing of medications for the treatment of co-occurring ADHD and ASD
6. List the main side effects of stimulants and non-stimulants, especially as seen in patients with ASD
7. Describe the clinical approach to a patient with autism spectrum disorder (ASD) and anxiety
8. Apply strategies regarding the titration and dosing of medications for the treatment of co-occurring anxiety and ASD
9. List the main side effects of selective serotonin reuptake inhibitors, especially as seen in patients with ASD
10. Describe the clinical approach to a patient with autism spectrum disorder (ASD) and irritability
11. Apply strategies regarding the titration and dosing of medications for the treatment of co-occurring irritability and ASD
12. List the main side effects of atypical antipsychotics, especially as seen in patients with ASD

Registration link: https://redcap.link/asdweb42025

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.  For any special requests, please contact the activity administrator before the meeting date.

---

Event Contact: Baconawa, Mariel at [email protected]

The University of California, Irvine School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.